Decision Analysis of the Benefits and Costs of Screening for Prostate Cancer
Annual rept. 27 Jul 2012-26 Jul 2013
DANA-FARBER CANCER INST BOSTON MA
Pagination or Media Count:
This annual report details the progress that has been made between August 2012 and August 2013, the fourth year of the Physician Research Training Award entitled Decision analysis of the benefits and costs of screening for prostate cancer . The goal of the proposed research is to develop a decision analytic model of PSA screening for prostate cancer. This model will permit the analysis of the effect of various PSA screening strategies on life expectancy LE, quality-adjusted LE QALE, and the cost-effectiveness of screening. The comparator will be a natural history model of unscreened, conservatively-treated prostate cancer based on primary data. It is hypothesized that the optimal screening strategies for prostate cancer will be dependent not only upon mortality benefit, but also upon the value patients place on health states and costs.
- Economics and Cost Analysis
- Medicine and Medical Research